Cancer Home > Zometa and Breastfeeding
It is not known whether it is safe for breastfeeding women to take Zometa. No studies have been conducted on whether the drug passes through breast milk, and it is unknown whether it might affect the growing bones of young infants. Since Zometa and breastfeeding may potentially be a dangerous combination, make sure to talk to your healthcare provider before taking the medication while breastfeeding.
Zometa® (zoledronic acid) is a medication used in cancer patients. It helps prevent bone problems and treats high blood calcium caused by cancer. At this time, it is not known whether Zometa passes through breast milk in humans. The manufacturer of Zometa does not recommend taking Zometa while breastfeeding. You should talk with your healthcare provider before taking Zometa if you are breastfeeding or thinking about breastfeeding.
No studies have been conducted on whether Zometa passes through breast milk in women. Like all bisphosphonate medications, Zometa binds to bone and is released very slowly over time. It is not known how Zometa might affect growing bones (such as those of young infants). Also, it is not known how long to wait after taking Zometa before it is safe to breastfeed.
You should talk with your healthcare provider about Zometa and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision about Zometa and breastfeeding that is right for you.